GMAB Competitors & Alternatives
Compare Genmab AS with similar stocks in the same industry
Biotechnology
GMAB
Main Stock$51.74
Tradestie Score
33
Market Cap
$19.56B
P/E Ratio
46.0
Revenue Growth
0.2%
Analyst Upside
+25.8%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARGX
argenx SE American Depositary Shares
|
$981.33
|
$46.96B | 33.9 | 31 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$415.96
|
$36.81B | 53.8 | 30 | Compare |
|
INSM
Insmed, Inc.
|
$118.07
|
$31.13B | - | 37 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$85.04
|
$24.57B | - | 52 | Compare |
|
INCY
Incyte Genomics Inc
|
$121.70
|
$16.93B | 62.4 | 50 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$68.97
|
$15.70B | 45.8 | 40 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.08
|
$15.22B | - | 48 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$267.07
|
$12.36B | 19.9 | 36 | Compare |
|
EXEL
Exelixis Inc
|
$69.84
|
$11.09B | 21.2 | 27 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$39.99
|
$10.76B | - | 31 | Compare |
More GMAB Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry